EDTUTC-4 New YorkLog in Sign up

NVS
Novartis AG
stockNYSEADR

Market OpenOct 5, 2026 2:39:34 PM EDT

140.35USD-0.461%(-0.65)810,102

140.30Bid140.33Ask0.03Spread

Pre-marketOct 5, 2026 9:28:30 AM EDT

140.93USD-0.050%(-0.07)

NVS News

Day breaks

02:33 PM EDTWhat's next for personalized mRNA cancer vaccines? ·

Seeking Alpha

08:45 AM EDTOMLYCLO® (omalizumab-igec), the first and only FDA-approved interchangeable biosimilar to XOLAIR®, now commercially available in the U.S. ·

PR Newswire

09:05 AM EDTNotable healthcare headlines for the week: Pfizer, Sanofi, and Novartis in focus ·

Seeking Alpha

01:04 PM EDTNovartis Signs Deal With Abogen For MRNA Therapies ·

RTTNews

07:32 AM EDTMedicare drug pricing model to affect only four firms after Trump’s MFN policy ·

Seeking Alpha

03:09 AM EDTNovartis inks up to $7.8B deal with Abogen for RNA-encoded therapeutics ·

Seeking Alpha

02:47 AM EDTNovartis Inks Chinese mRNA-Therapy Deal for Up to $7.8 Billion ·

Bloomberg

09:28 AM EDTMerck succeeds in mid-stage trial for skin disease drug ·

Seeking Alpha

03:00 PM EDTCatalyst Watch: Jobs report, Trump AI talks, and ticking fee time for Paramount ·

Seeking Alpha

03:36 PM EDTFDA commissioner nominee Overton rebuffs questions about Trump medical claims ·

Seeking Alpha

10:39 AM EDTLantheus gains approval of Bravnesta, generic competitor to Lutathera ·

Seeking Alpha

09:50 PM EDTNovartis (NVS) Faces Another Pipeline Setback as ALS Drug Fails Mid-Stage Trial ·

Insider Monkey

11:20 AM EDTCue Biopharma plummets on phase 2 data for chronic spontaneous urticaria asset ·

Seeking Alpha

07:08 AM EDTTrump administration is said to weigh allowing most pharma licensing deals with China ·

Seeking Alpha

11:20 PM EDTWhere Will CRISPR Therapeutics Be in 10 Years if Gene Editing Fulfills Its Promise? ·

The Motley Fool

11:00 PM EDTWhere Will CRISPR Therapeutics Be in 10 Years if Gene Editing Fulfills Its Promise? ·

The Motley Fool

08:07 PM EDTNovartis (NVS) Suffers its Third Drug Trial Setback in a Week, and its Worst Trading Day in Years ·

Insider Monkey

02:21 PM EDTLooming biosimilar void risks $189B in lost U.S. healthcare savings: report ·

Seeking Alpha

11:21 AM EDTNovartis (NVS) and Ionis (IONS)’ Big Cholesterol Bet Comes Up Short in Late-Stage Trial ·

Insider Monkey

02:20 PM EDTWorried About a Market Crash? This Dividend Stock Outperformed as the S&P 500 Sank in Both 2008 and 2022 ·

The Motley Fool